SCAP and neoplasm: The tumor inhibition rates (TIR) of Cap and Scap alone were only 8.24 and 5.29%, respectively, which could be attributed to insufficient drug accumulation in tumors (Fig. 4a–b and Supplementary Figs. 3, 4).